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The role of cell-surface sialic acid in the interaction of '2sI-labeled choriogonadotropin with gonadotropin 
receptors from plasma membranes of bovine corpus luteum was investigated. Pretreatment of plasma membranes 
with neuraminidases purified from Clostridium pecfringens or Vibrio cholerue enhanced the binding activity of 
1251-choriogonadotropin in a concentration-dependent manner. C. perfringens neuraminidase (100 mU/ml) and 
V. cholerue neuraminidase (1 .O I.U./ml) maximally stimulated gonadotropin-binding activity. The neuraminidase 
stimulation of binding was due to unmasking of gonadotropin-binding sites and not due to a change in affinity 
of the receptor for '251-choriogonadotropin. The activity of plasma-membrane 5'-nucleotidase, a glycoprotein 
enzyme, however, was not affected by neuraminidase treatment. The stimulatory effect of C. perfkingens enzyme 
was abolished by co-incubation of plasma membrane with glycoproteins, fetuin and mucin. Furthermore, the 
stimulatory effect of neuraminidase was due to an intrinsic property of the enzyme and was accompanied by a 
parallel dose-dependent loss of plasma-membrane-associated sialic acid residues. Other neuraminidase prepara- 
tions including that purified from Arthrobucter ureufuciens also enhanced 1251-choriogonadotropin binding with 
concomitant hydrolysis of plasma-membrane sialic acid. By contrast, enzyme purified from influenza virus did 
not release plasma-membrane sialic acid and consequently failed to modulate receptor activity. Treatment of 
plasma membrane with neuraminidase and subsequent fractionation demonstrated that the enzyme hydrolyzed 
50 - 60 %, sialic acid from glycoprotein and ganglioside components. Preincubation of plasma membrane with 
wheat-germ agglutinin partially blocked the hydrolysis of glycoprotein sialic acid as well as stimulation of 
1251-choriogonadotropin-binding activity. Incubation with other lectins, concanavalin A and peanut agglutinin, 
neither affected the hydrolysis of glycoprotein/ganglioside sialic acid by neuraminidase nor prevented the 
stimulatory action of enzyme on '251-choriogonadotropin-binding activity. These studies demonstrate a possible 
involvement of plasma-membrane-associated sialic acid (sialoglycoproteins) in the activity of gonadotropin 
receptors. 
In the ovary, gonadotropin-receptor interaction and sub- 
sequent expression of biological response(s) represent a com- 
plex process [l - 31. Although in recent years considerable 
studies have been reported regarding the properties of ovarian 
gonadotropin receptors in isolated systems [2 - 131, relatively 
little is known about the function of receptors within the 
membrane environment. Major membrane constituents, phos- 
pholipids and carbohydrate-containing structures, not only 
are required for structural integrity of active molecules in- 
cluding receptors but could also exert a regulatory role. The 
cell-surface carbohydrates originating from glycoproteins, 
glycolipids and mucopolysaccharides have often been re- 
ported to play important roles in cell-surface-mediated events 
including adhesion and recognition phenomena [14-161. Since 
cell-surface glycoproteins are localized mainly on the outer 
cell surface, the external orientation of carbohydrate groups 
makes them more suitable agents in the regulation of gonado- 
tropin receptor interaction and/or function. However, at 
present little information is available regarding the role of 
cell-surface carbohydrates in gonadotropin-receptor-mediated 
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events. Utilizing both the binding inhibition and fluorescence 
spectroscopy studies it has been demonstrated that glyco- 
protein hormones, thyrotropin, lutropin and choriogonado- 
tropin-like cholera toxin, interact with gangliosides [I7 - 211. 
Each hormone seems to recognize a specific oligosaccharide 
sequence on the ganglioside molecule [I 7,20,21]. Further, 
the inhibition in hormone binding by ganglioside was closely 
correlated with the number and location of the sialic acid 
residues within the ganglioside structures. However, earlier 
studies reported from this laboratory suggest that ganglio- 
sidcs play no obligatory role in gonadotropin interaction to 
ovarian plasma membranes and/or gonadotropin-induced 
ovarian responses [22- 241. By employing an entirely different 
experimental approach, Pacuszka et al. [25] reached a similar 
conclusion that gangliosides or ganglioside-like structures are 
not directly involved in choriogonadotropin interaction to 
testicular plasma membranes. Besides these studies, few in- 
vestigators have also reported modulation of gonadotropin 
binding to target plasma membranes of cells following incu- 
bation of membranes with relatively impure preparations of 
neuraminidase [4- 7,121. However, the exact mechanism or 
the specificity of the enzyme and whether the modulation 
of binding activity represented an intrinsic property of the 
enzyme were not established. 
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Previous studies from this laboratory suggest that phos- 
pholipids are required for structural integrity as well as for 
maximal activity of gonadotropin receptors associated with 
the plasma membrane bovine corpus luteum [26,27]. In con- 
tinuation of our efforts to understand and gain additional 
insight into the role of cell-membrane constituents in gonado- 
tropin-receptor interaction, we have now focused our atten- 
tion on the role of cell-surface carbohydrates in these pro- 
cesses. In the present studies we have chosen sialic acid as a 
representative of cell-surface carbohydrates and attempted 
to modify the existing concentration of this sugar residue in 
glycoprotein and ganglioside fractions by neuraminidase 
treatment and to monitor accompanying changes in cell- 
surface sialic acid and in the properties of gonadotropin- 
receptor interaction. Our results demonstrate that enzymatic 
removal of cell-surface sialic acid led to the unmasking and 
stimulation of gonadotropin receptor activity in plasma 
membranes of bovine corpus luteum. Further, a relationship 
between gonadotropin-receptor interaction and glycoprotein- 
bound sialic acid is demonstrated. These studies thus demon- 
strate a potential regulatory role of sialoglycoprotein(s) in 
gonadotropin interaction with plasma-membrane-associated 
receptors. 
MATERIALS AND METHODS 
Bovine corpora lutea obtained from a slaughterhouse 
(Murco Slaughterhous, Plainwell, MI) were transported to 
the laboratory in ice-cold normal saline. They were kept 
frozen at - 80 "C until use. Concanavalin A (extracted from 
Canavalia ensformis), purified neuraminidase from Clostri- 
dium perfringens (type V, 0.31 U/mg protein usingN-acetyl- 
neuraminyl-lactose, 0.17 U/mg protein using bovine sub- 
maxillary mucin), chromatographically purified neuramin- 
idase from C. perjiingens (type VI, 5.4 U/mg protein using 
N-acetylneuraminyl-lactose ; 2.3 units/mg protein using bo- 
vine submaxillary mucin) and neuraminidase purified by 
affinity chromatography from C. perfringens (type IX, 30- 
50 U/mg protein using N-acetylneuraminyl-lactose) were 
purchased from Sigma Chemical Company. Wheat-germ 
agglutinin (extracted from Triticum vulgaric), peanut agglu- 
tinin (extracted from Arachis hypogea), purified neuraminidase 
from Arthrobacter ureafaciens (50 U/mg protein using N -  
acetylneuraminyl-lactose), purified neuraminidase from In- 
fluenza virus (1.6 U/mg at 37 at pH 5.6 using N-acetyl- 
neuraminyl-lactose) and purified neuraminidase from Vibrio 
cholerae (500 U/ml using N-acetylneuraminyl-lactose) were 
purchased from Calbiochem-Behring Corp. Purified neur- 
aminidase from C. perfringens (0.6 U/mg dry powder using 
bovine submaxillary mucin) and purified neuraminidase ex- 
tracted from C. perfringens (0.5 U/mg using bovine sub- 
maxillary mucin) were supplied by Boehringer-Mannheim 
Corp. and United States Biochemical Corp., respectively. 
Other reagents used were of analytical grade. "'I-chorio- 
gonadotropin was prepared according to Dufau et al. [28]. 
Preparation of' Plasma Membranes qf Bovine Corpus Luteum 
Plasma membranes were prepared from bovine corpora 
lutea as previously described [26,27] according to the proce- 
dure of Gospodarowicz [4] and were kept frozen at - 20°C 
until use. Protein was assayed according to the procedure of 
Lowry et al. [29] using bovine serum albumin as standard. 
Neuraminidase Treatment of Plasma Membranes 
The plasma membranes from bovine corpus luteum were 
centrifuged at 10000 x g for 15 min and resuspended in Tris 
buffer (10 mM Tris/HCl pH 7.4; 1 mM CaC12) at a protein 
concentration of 1 mg/ml. Unless otherwise indicated the 
membranes were incubated with 100 mU/ml neuraminidase. 
Where required, 0.1 mg/ml mucin, fetuin or bovine serum 
albumin were also added. After incubation usually at 37 "C 
for 60 min, 5 ml Tris buffer was added and membranes were 
sedimented by centrifugation at 10000xg for 15 min. The 
membrane were washed three times with excess Tris buffer. 
The membranes treated with neuraminidase and buffer (con- 
trol) were then assayed for binding of 1251-choriogonado- 
tropin, activity of 5'-nucleotidase and content of sialic acid 
as described below. 
Gonadotropin Binding to Plasma Membranes 
of Bovine Corpus Luteum 
The assay for specific binding of 1251-choriogonadotropin 
to plasma membranes was carried out by a slight modifica- 
tion of the procedure described earlier from this laboratory 
[26,27]. Briefly, aliquots of membrane fractions containing 
known amounts of protein ( z  100 pg) were usually incubated 
at 37 "C for 60 min in 0.3 ml Tris/albumin buffer (10 mM 
Tris/HCl pH 7.4; 1 mM CaC12, and 0.1 "/, bovine serum 
albumin) with "'I-choriogonadotropin (80000- 120000 
counts/min; 20- 50 counts x min-I x pg choriogonadotro- 
pin-'). Following incubation, 0.2 ml of 0.1 M sodium phos- 
phate buffer pH 7.0, 0.5 ml of 0.2 o/, bovine immunoglobulin 
(w/v) in phosphate buffer and 1 ml of 25% poly(ethy1ene- 
glycol) (Carbowax 6000, Union Carbide, w/v) in phosphate- 
buffered saline were added. After rapid mixing, the tubes 
were left on ice for 10 min, centrifuged at 1500 x g for 20 min 
at 4 "C and the supernatants were aspirated. The precipitates 
were resuspended in 1 ml of phosphate buffer and following 
addition of 1 ml of 25 % poly(ethyleneglycol), the tubes were 
centrifuged and the supernatants aspirated. The tubes con- 
taining sedimented precipitate (bound hormone) were counted 
for radioactivity in an automatic y-spectrometer (Searle 
Analytic, model 1195). The specific binding of 12'I-chorio- 
gonadotropin was determined by subtracting from total radio- 
activity (in counts/min) the radioactivity that remained asso- 
ciated with the membrane fraction in the presence of a 1000- 
fold excess of unlabeled choriogonadotropin. 
Determination of' Sialic Acid 
Sialic acid was assayed by the colorimetric procedure of 
Aminoff [30]. Membranes (1 mg protein) pretreated with 
buffer or neuraminidase (as described above) were incubated 
with 1 ml of 0.05 M HzS04 at 80 "C for 1 h. After incubation, 
the samples were cooled to 4 "C and centrifuged at 15 000 x g 
for 10 min. Aliquots (0.5 ml) of the clear supernatant were 
assayed for sialic acid [30]. Sialic acid hydrolyzed by neur- 
aminidase was then calculated from the difference between 
buffer-treated and the enzyme-treated membranes [31]. 
Fractionation of Plasma Membrane Sialic Acid 
into Ganglioside and Glycoprotein Fractions 
Unless otherwise stated neuraminidase-treated and buffer- 
treated membranes were fractionated into ganglioside and 
glycoprotein fractions according to the procedure of Tetta- 
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manti et al. [32].  Briefly, membranes (approximately 10 mg 
protein) in 0.5 ml of 10 mM potassium phosphate buffer 
pH 6.8 were extracted with 4 ml of tetrahydrofuran. The 
suspension was centrifuged at 5000 x g for 10 min at 15 "C. 
The supernatants were saved. The sedimented pellet was 
extracted three times with 0.5 ml buffer and 2 ml of tetra- 
hydrofuran. To the pooled fractions, 0.3 vol. of diethyl ether 
was added and the tubes were vortexed for 2 min, then 
centrifuged at 5OOOxg for 10min at 15°C. The aqueous 
phase was saved and organic phase after the addition of 
0.1 vol. of glass-distilled water was vortexed and centrifuged 
as above. The pooled aqueous phase from each sample after 
initial concentration in vacuum was extensively dialyzed 
against distilled water for 3 days with at least three changes 
a day. The dialyzed fraction was lyophilized and referred to 
as 'ganglioside fraction'. The tetrahydrofuran-extracted plas- 
ma-membrane residues which contained glycoproteins and 
the extracted ganglioside fractions were hydrolyzed in 0.05 M 
H2S04 for 1 h at 80°C [31,33] and released sialic acid was 
quantified by the colorimetric procedure of Aminoff [30]. 
One-hour hydrolysis in 0.05 M HzS04 was found sufficient 
to quantitatively release all the bound sialic acid from glyco- 
protein and ganglioside fractions. In some cases gangliosides 
from plasma membranes of bovine corpus luteum were also 
extracted according to the published procedures of Suzuki 
[34], Ledeen et al. [35] and Harth et al. [36]. The sedimented 
residue in each case was used to quantify glycoprotein sialic 
acid. Thin-layer chromatography of gangliosides was per- 
formed as described earlier [24]. 
Enzyme A.ssays 
Neuraminidase was assayed according to Cassidy et al. 
[37] and 5'-nucleotidase was determined by a modification 
of the method of Solyom and Trams [38]. Incubation mixtures 
for 5'-nucleotidase in a final volume of 1 ml contained 
75 mM Tris/HCI pH 9.0, 10 mM KCI, 5 mM MgC12, 5 mM 
5'AMP, and 50- 100 pg of enzyme protein. Incubations 
were carried out at 37 "C for 15 min. The reaction was stopped 
by the addition of 1 ml of 10% trichloroacetic acid (w/v). 
After centrifugation, aliquots (0.5 ml) of clear supernatants 
were assayed for liberated phosphate by the method of Fiske 
and Subbarow [39]. ATPase activity was assayed according 
to Kimelberg and Papahadjopoulos [40]. 
RESULTS 
Effect of Incubation p H  
on Neuraminidase-Stimulated Receptor Activity 
Since neuraminidases exhibit optimum pH in acidic range 
[37], we tested the ability of the enzyme to stimulate the 
receptor at pH 5.0, 6.0, 7.0 and 7.5. As shown in Fig. 1, at 
all pH values tested, neuraminidase effectively stimulated 
'2sI-choriogonadotropin binding. Similarly, the extent of 
stimulation was more or less constant although the receptor 
activity itself was less stable around pH 5.0. In subsequent 
experiments, plasma membranes were pretreated with neur- 
aminidase at pH 7.4. 
Effect of Increasing Concentrations of Neuruminiduse 
on Plasma-Membrane-Associated Sialic Acid 
and Gonadotropin-BindiFtiuzg Activity 
Since the stimulatory effect of neuraminidase presumably 
results from the hydrolysis of plasma-membrane-bound sialic 
" 
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Fig. 1. Ej'ect of varying incubation p H  on neuruminidase-stimulated '2sI- 
choriogonadotropin-binding activity. Plasma membranes (5  1 mg protein) 
were pretreated with or without 100 mU C. perfringens neuraminidase 
(Sigma type V) at indicated pH for 60 min at 37 "C. After incubation, 
the membrane preparations were washed in Tris buffer and assayed for 
'251-choriogonadotropin binding. For pH 5.0 and 6.0 acetate buffer, 
pH 7.0 morpholinopropanesulfonic acid/NaOH and pH 7.5 Tris/HCl 
buffer were used. (D) Buffer-treated membranes; (0) neuraminidase- 
treated membranes. The concentration of '251-choriogonadotropin used 
was 4.8 ng (120000 counts/min). Results are mean S.E.M. 
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Fig. 2. Eflect of incubation of plasma membrane.c. with increasing concen- 
trations of neuraminidase on '2'I-choriogonadotropin binding and extent 
uf hydro1ysi.r of membrane-bound sialic acid. Two sets of plasma mem- 
branes (1 mg protein) were incubated with indicated concentrations of 
neuraminidase. After enzymic treatment and washing of plasma mem- 
branes, one set of membranes were used to monitor '"I-choriogonado- 
tropin-binding activity (0). Samples from other set of membranes were 
extracted in 0.05 M H2S04 and released sialic acid was assayed colori- 
metrically as described in Materials and Methods (a). The concentration 
of "'I-choriogonadotropin used was 3.8 mg (95000 counts/min). Results 
are mean S.E.M. 
acid, we examined this possibility by measuring sialic acid 
release from membranes following neuraminidase treatment 
concomitant with '251-choriogonadotropin-binding measure- 
ments. Treatment of membranes with neuraminidase resulted 
in progressive loss of cell-surface sialic acid with concomitant 
increase in '251-choriogonadotropin-binding activity (Fig. 2). 
The maximum hydrolysis of membrane-bound sialic acid 
was observed to 100 mU/ml of enzyme. Interestingly, the 
same concentrations of enzyme also maximally enhanced the 
'251-choriogonadotropin-binding activity. 
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Table 1. Effect of addition of mixed gungliosides, vurious glycoproteins, 
and neuraminidases on 'Z51-choriogonadotropin binding to plasma mem- 
branes of bovine corpus luteum 
Aliquots of plasma membranes from bovine corpus luteum were cen- 
trifuged at  10000 x g for 15 min in the cold and resuspended in Tris buffer 
at a protein concentration of 1 mg/ml. Aliquots of membranes were 
incubated with indicated concentrations of various neuraminidase prepa- 
rations. In the case of experiment 1 and 2, indicated concentrations of 
mucin, fetuin, bovine serum albumin or mixed brain gangliosides were 
also added. After incubation at 37°C for 60 min, 5 ml Tris buffer was 
added and XnembrdneS were sedimented by centrifugation at 10000 x g  
for 15 min. The membranes were washed three times with excess buffer. 
The resultant membranes were then assayed for '251-choriogonado- 
tropin binding 5'-nucleotidase or sialic acid content as described in 
Materials and Methods. The concentration of '251-choriogonadotropin 
used was 4 ng (120000 counts/min). Results are + S.E.M. 
Additions x 1251- Sialic acid 
choriogonado- 
tropin bound 
counts x min-' pg/mg 
x mg protein-' protein 
Experiment I 
None 
Neuraminidase (100 mU/ml) 
Fetuin (0.1 mg/ml) 
Nauraminidase (100 mU/ml) 
Mucin (0.1 mg/ml) 
Mucin (0.1 mgjml) 
+ neuraminidase (100 mU/ml) 
Bovine serum albumin (0.1 mg/ml) 
Bovine serum albumin (0.1 mg/ml) 
+ neuraminidase (1 00 mUjml) 
+ fetuin (0.1 mg/ml) 
Experiment 2 
None 
Bovine-brain mixed gangliosides 
Neuraminidase (100 mU/ml) 





Purified C. perfringens neuraminidase 
(Sigma type V, 0.31 U/mg protein) 
Chromatographically purified 
C. perfringens neuraminidase 
(Sigma type VI, 5.6 U/mg protein) 
C. perfringens neuraminidase purified 
by affinity chromatography 
(Sigma type IX, 30- 50 U/mg protein) 
(U.S. Biochemical Corp., 
0.5 U/mg rotein) 
Purified C. perfringens neuraminidase 
(Boehringer-Mannheim, Corp., 
0.6 U/mg dry powder) 
Purified C. perfringens neuraminidase 
E-xperiment 4 
None 
C.pecfringen.5 neuraminidase (0.1 Ujml) 
V. cholerae neuraminidase ( 1  Ujml) 
Influenza virus neuraminidase ( 1  Ujml) 
A .  ureufaciens neuraminidase (0.1 U/ml) 
64.4 + 2.14 
78.5 + 1.29 
75.1 & 1.9 
70.7 f 3.7 
77.4 * 1.0 
75.2 & 0.8 
134 + 4.0 
114 k 3.4 
84 k 4.5 
79 k 7.8 
183 +14 
128 + 9 
74.71 + 4.9 8.47 k 0.9 
148 + I 0  3.42 & 0.37 
139 k 2 3.55 k 0.29 
152 f 7 3.70 + 0.24 
130 k 6 5.1 f 0.73 
128 +13 5.3 + 0.33 
127 k 4 11.68 f 0.26 
196 f 1.8 5.6 + 0.27 
167 f 2.2 6.39 + 0.6 
137 f 3.9 11.34 & 0.37 
175 f 5.5 7.13 + 0.30 
Effect of Various Glycoproteins, Gangliosides 
and Different Preparations of Neuraminidase 
on Gonadotropin Receptor Activity 
Since sialic-acid-containing glycoprotein and gangliosides 
are suitable substrates for neuraminidase, it was of interest 
to see if coincubation of membrane with these substances 
could block subsequent enzyme-stimulated binding activity. 
Results presented in Table 1 show that fetuin and mucin 
effectively blocked the stimulatory effect when added along 
with neuraminidase. Addition of mixed gangliosides (bovine 
brain) partially reversed the stimulatory effect of neuramin- 
idase on '251-choriogonadotropin binding to plasma mem- 
branes although this effect was less pronounced compared 
to mucin or fetuin. By contrast, addition of these agents or 
different concentrations of N-acetylneuraminic acid (up to 
200 pg/ml) to plasma membranes pretreated with neuramin- 
idase did not affect neuraminidase-stimulated activity (data 
not shown). Both chromatographically purified preparation 
and the enzyme purified by affinity chromatography stimu- 
lated '251-choriogonadotropin binding and hydrolysis of 
sialic acid to the same extent (Table 1, experiment 3). These 
results were comparable to the results obtained with the 
enzyme purified by salt fractionation (Sigma, type V). In 
contrast, two other preparations of Clostridium perfkingens 
neuraminidase, although enhanced gonadotropin binding 
and sialic acid hydrolysis, were slightly less effective when 
compared to the type-V enzyme. The effect of neuraminidases 
isolated from C.  perfringens, Vibrio cholerae, influenza virus 
and Arthobacter ureafaciens on l2'1-choriogonadotropin bind- 
ing and sialic acid hydrolysis is shown in Table 1 (experi- 
ment 4). Among these preparations, the C.  perfringens enzyme 
was most effective followed by the V. cholerae and A. urea- 
faciens enzymes. Contrary to its stimulation of binding 
activity, the A.  ureafaciens enzyme, however, released less 
sialic acid from plasma membranes compared to the V. 
cholerae as well as the C. perfringens enzyme. Neuraminidase 
purified from influenza virus showed no significant effect 
either on the binding or on the hydrolysis of plasma- 
membrane-bound sialic acid. 
Effect of Increasing '251-Choriogonadotropin Concentrations 
on Neuraminidase-Stimulated Gonadotropin Receptor Activity 
Results presented in Fig. 3 demonstrate Scatchard plot 
[41] analysis of '251-choriogonadotropin binding to plasma 
membranes previously exposed to neuraminidase. It is evident 
that the neuraminidase treatment unmasked and increased 
the gonadotropin-binding sites without any significant effect 
upon the affinity of receptor for the hormone. The buffer- 
treated membranes contained 70.9 fmol binding sites/mg 
protein while neuraminidase treatment increased the number 
of binding sites to 101 fmol/mg protein. The dissociation 
constants (&) for buffer-treated and neuraminidase-treated 
membranes were 1.04 x lo-'' M and 0.8 x lo-'' M, respec- 
tively. 
Lack of Effect of Neuraminidase on Glycoprotein Enzymes, 
5'-Nucleotidase and A TPase 
To rule out the nonspecific effect of neuraminidase on 
gonadotropin receptor activity, we also studied the effect of 
this enzyme on 5'-nucleotidase and ATPase. 5'-Nucleotidase 
activity was extremely susceptible to concanavalin A and 
almost 80% of the activity was inhibited by the addition of 
10 pg/ml of this lectin. Higher concentrations of wheat-germ 
i 
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Fig. 3. Scatchard plot of gonadotropin binding to buffer-treated and 
neuraminidase-treated membrane in the presence of increasing concentra- 
tions qf 'Z51-choriogonadotropin. Plasma membranes (% 1 mg/ml) were 
incubated without or with 100 mU/ml of C. perfringens neuraminidase 
(Sigma, type V) for 60 min at  37 "C. Following washing of membranes, 
suitable aliquots (2 100 pg membrane proteins in triplicate) were in- 
cubated with increasing concentrations of '251-choriogonadotropin 
(starting from 10000- 150000 counts/min) a t  37°C for 60 min. Other 
details were similar to that described in Materials and Methods. The 
values bound and free were then utilized to construct a Scatchard plot 
[41]. (00) Buffer-treated membranes; ( 0 0 )  neuraminidase- 
treated membranes 
agglutinin also inhibited the enzyme activity although the 
extent of inhibition was less pronounced compared to con- 
canavalin A. Addition of specific sugars cc-methyl-D-pyranoside 
(50 mM) and N-acetyl-~-glucosamine (50 mM) completely 
reversed the inhibitory action of concanavalin A and wheat- 
germ agglutinin, respectively. By contrast, 5'-nucleotidase 
activity was not affected by neuraminidase treatment. ATPase 
activity was also partly inhibited by concanavalin A. Different 
concentrations of neuraminidase from 10 mU/ml to 1000 m u /  
ml failed to modulate 5'-nucleotidase activity (data not shown). 
Neuraminidase-Mediated Hydrolysis of Glycoprotein-Bound 
and Ganglioside-Bound Sialic Acid,from Plasma Membrane 
Results presented in Table 2 compare the sialic acid con- 
tent of ganglioside and glycoprotein fractions isolated by 
different procedures. The percentage of sialic acid recovered 
in glycoprotein and ganglioside fractions isolated by four 
different procedures was more or less comparable. However, 
the procedure of Tettamanti et al. [32] was of choice because 
of its simplicity and it requires much lower amount of 
membranes (10 mg protein) compared to the other procedures 
(at least 50 mg protein). Isolated fractions were also charac- 
terized by thin-layer chromatography using the procedure 
described earlier from this laboratory [24]. Thin-layer chro- 
matography of the ganglioside fraction demonstrated that 
more than 95% of total sialic acid applied was recovered in 
separated gangliosides. In contrast, thin-layer chromatog- 
raphy of the glycoprotein fraction failed to show the pres- 
ence of ganglioside. 
Results presented in Table 3 show the distribution and 
hydrolysis of sialic acid in glycoprotein and ganglioside com- 
ponents of plasma membranes. The ganglioside fraction con- 
tained approximately 2.5-times more sialic acid than the 
glycoprotein fraction. Treatment of plasma membranes with 
neuraminidase, however, hydrolyzed 50 - 60 sialic acid from 
Table 2. Comparison of various extraction procedures on the recoverv of 
siulic acid ganglioside and glycoprotein fraclions qf plasma membrunes 
,from bovine corpus luteum 
Total sialic acid content of isolated corpus luteum plasma membrane 
was 13.75 f 0.47 pg/mg protein f S.E.M. The results are means of three 
different experiments 
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Table 3. Stimulation of gonadotropin receptor activit.): and hydro1.v.vi.s of 
gangliosidt,-a.P.sociated and glycoprotein-associaled .siulic acid of plci.sma 
membrane.s ,from bovine corpus luteunz by  neuraminidase 
Plasma membranes were trcated with C.pcvfringeiis neuraminidase as 
described in Table 1. The gangliosides and glycoprotein fraction were 
isolated and assayed for sialic acid as  described in Materials and Methods. 
The concentration of '251-choriogonadotropin used wa5 4 ng (80000 
countsjmin). Results are S.E.M. 
Additions Sialic acid '2'1-chorio- 
go n d d o - _____ 
totdl ganglio- glyco- lropin 
sides protein bound 
pg/mg protein counts 
x m i n - '  
x mg 
protein- ' 
None 12.09 0.82 7.81 k 0.43 2.97 -t 0.22 85.6 i 7.8 
Ncuraminidase 5.37 f 0.26 3.93 ? 0.12 1.32 i 0.08 154 f 11.7 
both fractions (Table 3). Under identical experimental con- 
ditions, '251-choriogonadotropin-binding activity was en- 
hanced from 85.6 & 7.8 x counts bound x min-' x mg 
protein-' to 154 1 1 . 7 ~  10-3counts bound x min-'xmg 
protein-'. 
Role of Glycoprotein-Associated Sialic Acid 
in Gonadotropin-Receptor Interaction 
Since in the above experiments (Table 3) neuraminidase 
treatment released 50- 60 % sialic acid from glycoprotein 
and ganglioside components, further experiments were per- 
formed to investigate which of the component plays a role 
in gonadotropin-receptor interaction. Since wheat-germ agglu- 
tinin also interacts with the terminal sialic acid [43-461 in 
addition to N-acetyl-D-glucosamine [42], we made use of this 
lectin to declineate the role of ganglioside and/or glycoprotein 
sialic acid in hormone-receptor interaction. Results presented 
in Table 4 demonstrate the effect of pretreatment of plasma 
membranes with wheat-germ agglutinin, concanavalin A, or 
peanut agglutinin on subsequent hydrolysis of sialic acid and 
the stimulation of 1251-choriogonadotropin-binding activity 
by neuraminidase. Wheat-germ agglutinin treatment of mem- 
branes significantly blocked (57 %) the hydrolysis of glyco- 
protein sialic acid while it only slightly reduced the extent of 
hydrolysis of ganglioside sialic acid. Under identical condi- 
tions, interestingly, wheat-germ agglutinin also partially pre- 
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Table 4. Effect of various plant lectins on sialic acid hydrolysis ,from 
plasma membranes of bovine corpus luteum by neuraminidase 
Aliquots of plasma membranes (1 mg/ml) were first incubated with or 
without lectins and incubated at 30 "C for 30 min. At the end of incubation 
C.  perfringens neuraminidase was added and incubation continued at  
37°C for 60 min. After the second incubation one set of membranes 
was processed for extraction and quantification of ganglioside-associated 
and glycoprotein-associated sialic acid. The other set of membranes 
was then incubated either with no sugar or with a-methyl-o-mannoside 
(50 mM for concanavalin A), N-acetyl-o-glucosamine (50 mM) along 
with N-acetylneuraminic acid (10 mM both for wheat-germ agglutinin) 
or galactose (50 mM for peanut agglutinin) to remove plasma-membrane- 
bound lectins. The sugar-treated membranes were then assayed for Iz5I- 
choriogonadotropin binding as described in Materials and Methods. 
The concentrations of '251-choriogonadotropin used was 4 ng (100000 
counts/min). Sialic acid is expressed as a percentage of the sialic acid 
released from control membranes not preexposed. '251-choriogonado- 
tropin is expressed as a percentage of that bound from control mem- 
brane not preexposed to lectins 
Additions Lectin Sialic acid 'z51-chorio- 
concen- gonado- 
tration glyco- ganglio- tropin 
protein sides bound 
Neuraminidase 0 100 100 100 
Wheat-germ 
agglutinin 750 4 3 + 6  8 6 k 4  4 6 + 3  
Concanavalin A 1000 8 7 k 5  9 1 k 6  9 2 + 2  
Peanut agglutinin 750 98 k 1 97 k 2 100 
vented the stimulatory action of neuraminidase on '251-chorio- 
gonadotropin-binding activity. By contrast, a-methyl-D-man- 
noside (concanavalin A) and galactose (peanut agglutinin) 
specific lectins were without any effect either in the hydrolysis 
of membrane-associated sialic acid or on gonadotropin- 
receptor activity. These studies thus establish a direct rela- 
tionship between sialic acid content of glycoprotein and 
gonadotropin receptor activity. Furthermore, it is also evident 
from these studies that sialoglycoprotein(s) play a major 
regulatory role in gonadotropin-receptor interactions. 
DISCUSSION 
Earlier studies have described physico-chemical properties 
of gonadotropin-receptors of ovarian tissues [4 - 111. How- 
ever, precise knowledge about the function of gonadotropin 
receptors within the membrane environment and the regula- 
tory role exerted by major membrane constituents in gonado- 
tropin-receptor interaction is not established. Previous studies 
from this laboratory suggest that phospholipids are required 
for structural integrity as well as for maximal activity of 
gonadotropin receptors associated with the membrane of 
bovine corpus luteum [26,27]. By contrast, we have shown 
that gangliosides play no major role in gonadotropin inter- 
action to ovarian plasma membranes and/or in receptor- 
mediated and tropic-hormone-induced responses [22 - 241. 
Thus, incubation of ovarian plasma membranes or cells with 
various gangliosides failed to modulate '251-choriogonado- 
tropin binding or production of cyclic AMP and progesterone. 
Under identical experimental conditions the action of cholera 
toxin which specifically interacts with GMl [47-491 was 
blocked by coincubation with gangliosides [22 - 241. Although 
gangliosides were previously shown to inhibit thyrotropin, 
lutropin and choriogonadotropin binding to target cell mem- 
branes [17-211 the subsequent studies by Pacuszka et al. 
[25] suggest that this phenomenon may not have any physio- 
logical significance. They were able to observe ganglioside- 
mediated inhibition of '251-choriogonadotropin binding to 
testicular plasma membranes when binding studies were per- 
formed under nonphysiological conditions (low ionic strength 
buffer, 0.025 mM Trislacetate buffer pH 6; 0.6% bovine 
serum albumin) and 2500-fold excess unlabeled choriogonado- 
tropin did not block 1251-choriogonadotropin binding. In 
contrast, when the binding assay was carried out in physio- 
logical buffer [50] and where binding was blocked by 250-fold 
excess choriogonadotropin (designated as 'specific binding') 
gangliosides were found to be noninhibitory [25]. Thus, 
studies from our laboratory as well as by Pacuszka et al. [25] 
support the notion that gangliosides or ganglioside-like struc- 
tures are not involved in gonadotropin-receptor interaction 
and do not play a direct role in transmitting the hormonal 
signals across the gonadal tissue plasma membranes. In the 
present studies we have used neuraminidase to modify cell- 
surface sialic acid content in order to identify the role of cell- 
surface carbohydrates in gonadotropin-receptor interaction. 
These studies suggest that changes in the plasma-membrane 
sialic acid (glycoprotein) content lead to modulation of 
gonadotropin-receptor interaction so as to increase the 
hormone-binding capacity. We have presented evidence that 
neuraminidase stimulation of gonadotropin receptor activity 
was due to intrinsic activity rather than a nonspecific en- 
zymatic contamination. This conclusion was supported by 
the following points. (a) Different preparations of Clostri- 
dium perfringens purified to varying extents stimulated lz5I- 
choriogonadotropin binding equally when plasma mem- 
branes were exposed to a fixed (100 mU/ml) concentration 
of these preparations; (b) the stimulatory effect of neur- 
aminidase was blocked by coincubation with the glycoprotein 
mucin, fetuin or bovine brain mixed gangliosides ; (c) the 
activity of 5'-nucleotidase, a glycoprotein enzyme, was not 
affected by neuraminidase treatment; and (d) the extent of 
stimulation of binding activity was followed by parallel 
hydrolysis of cell-surface sialic acid. 
Although C. perfringens and Vibrio cholerae enzymes were 
equally effective in unmasking gonadotropin-binding activity, 
the optimum concentrations of these two were quite different. 
The requirement for higher amounts of V. cholerae enzyme, 
however, cannot be explained on the basis of differences in 
enzyme properties since both of these bacterial enzymes have 
been reported to exhibit similar properties [37,51,52]. The 
structure of the substrate to some extent can influence the 
rate, although prolonged incubation and/or higher concen- 
trations of either enzyme could result in the liberation of 
essentially all of the accessible sialic acid residues [37,51,52]. 
The rate of hydrolysis of plasma-membrane sialic acid by 
these two enzymes, therefore, could be influenced not only 
by the position of sialic acid linkage to the penultimate sugar 
in the carbohydrate chain [37], but may also be dependent 
upon the incubation time. 
Fractionation of plasma membranes into glycoprotein and 
ganglioside revealed that neuraminidase released 50 - 60 % 
of the bound sialic acid from these fractions. The partial 
release may be due to unique topographical arrangements 
of gangliosides and glycoproteins in such a way that remaining 
sialic acid residues are inaccessible to the enzyme or may 
represent specificity of the enzymes toward certain class of 
oligosaccharides from glycoconjugates or both. The fact that 
neuraminidase hydrolysis of sialic acid bound to glycopro- 
teins is partially blocked by wheat-germ agglutinin along with 
corresponding decrease in enzyme-stimulated '251-chorio- 
gonadotropin-binding activity allows us to propose a role 
for glycoprotein, including sialic acid, in gonadotropin- 
receptor intcraction. The extreme susceptibility of these glyco- 
proteins to neuraminidase leaves little doubt that these are 
present as external constituents of plasma membranes with 
exposed oligosaccharide groups. The inability of concana- 
valin A and peanut agglutinin to protect sialoglycoprotein 
hydrolysis not only suggests that oligosaccharides that bind 
concanavalin A and peanut agglutinin are quite separable 
from that of sialic-acid-containing oligosaccharides, but also 
suggests a unique regulatory role of sialic acid in gonado- 
tropin-receptor interaction. Previously sialoglycoproteins have 
been assigned a regulatory role in neurotransmitter [53], 
cation [54] and wheat-germ agglutinin [31] interaction to 
their receptors. Similarly, removal of surface sialic acid leads 
to inhibition of synaptic transmission [55]  and neuraminidase 
treatment of liver plasma membranes is reported to enhance 
the ability of these membranes to bind cholera enterotoxin 
(561. The elegant work of Ashwell and associates have shown 
that removal of terminal sialic acid residue from serum glyco- 
proteins lead to specific binding of these proteins to liver 
plasma membranes and subsequent rapid clearance from the 
circulation [57 - 601. Further incubation of thyroid plasma 
membranes with N-acetylneuramic acid was shown to enhance 
'251-thyrotropin-binding activity, although neuraminidase 
removal of plasma membrane sialic acid did not affect 
hormone binding [61]. 
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